HIV-1, the brain, and combination therapy

The Lancet

Volumn 346, Issue 8985, 1995, Pages 1244-1245

  Portegies, Peter ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NIMODIPINE; PENTOXIFYLLINE; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ATTENTION; BRAIN DISEASE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; DISEASE COURSE; DRUG PENETRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0028786146     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91857-4     Document Type: Article

References (16)

1. The AIDS dementia complex, 1: clinical features
2. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, the Netherlands
3. Management of AIDS dementia complex and HIV-1 infection of the nervous system
4. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment
5. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial
6. Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine
7. Cerebrospinal fluid beta-2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment
8. Reduced frequency of HIV-infected brain lesions in patients treated with zidovudine
9. Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey
10. Changing incidence of HIV-induced brain lesions in Oslo, 1983-1994: effects of zidovudine treatment
11. AIDS dementia complex a review
12. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection
13. AIDS dementia complex and didanosine
14. Combination superior to zidovudine in Delta trial
15. Zidovudine-resistant variants of HIV-1 in brain
16. In vivo comparison of zidovudine resistant mutations in blood and CSF of HIV-1 infected patients